BusinessHealthNews

HBM Group to Set up Syringe Production Plant in Ethiopia

ADDIS ABABA – China’s HBM Group revealed its plan to set up a pharmaceutical manufacturing plant in Ethiopia with a capacity to produce a million syringes per day.

The plan was announced by HBM Group owner Gordon during his meeting with the CEO of the Industrial Development Corporation (IPDC), Aklilu Tadesse on Friday.

The IPDC, a public enterprise, manages twelve state-owned industrial parks across Ethiopia, hosting manufacturing companies from a range of countries across the world.

The Chinese company plans to erect the manufacturing plant at Kilinto Industry Park, which, the IPDC CEO said, has become “one of the best and most competitive pharmaceutical centers.”

The HBM Group executives previously visited Kilinto Industrial Park and were impressed by the infrastructure and service approach they saw in the Park.

That helped them to make the latest decision, per the IPDC.

The owner of HBM Group Gordon informed the IPDC officials of his new plans to build “a world-class” syringe factory in Kilinto Industrial Park.

The plant will have the capacity to produce more than a million syringes per day and 300 million plus per year, the owner stated.

The New York-headquartered HBM Group manufactures various medical equipment and is a leader in the field in China.

Its investment in Klinto, Aklilu said, would support Ethiopia’s efforts to replace the imported medical equipment in addition to contributing to technology and knowledge transfer in the sector.

The pharmaceutical company has been cooperating with the Ethiopian Pharmaceuticals Supply Agency (EPSA ) for the past 8 years and exports its products to more than 100 countries around the world.

One thought on “HBM Group to Set up Syringe Production Plant in Ethiopia

Comments are closed.